Olink Holding AB (publ) (NASDAQ:OLK) Stake Lessened by Magnetar Financial LLC

Magnetar Financial LLC trimmed its stake in shares of Olink Holding AB (publ) (NASDAQ:OLK) by 0.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,040,732 shares of the company’s stock after selling 8,319 shares during the quarter. Magnetar Financial LLC owned approximately 1.64% of Olink Holding AB (publ) worth $51,998,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Virtu Financial LLC acquired a new position in Olink Holding AB (publ) in the fourth quarter worth about $1,061,000. Nomura Holdings Inc. bought a new position in Olink Holding AB (publ) in the 4th quarter worth approximately $3,115,000. Water Island Capital LLC acquired a new position in Olink Holding AB (publ) during the 4th quarter worth $41,360,000. Flow State Investments L.P. acquired a new position in shares of Olink Holding AB (publ) during the fourth quarter valued at $1,509,000. Finally, FIL Ltd acquired a new position in Olink Holding AB (publ) during the 4th quarter valued at about $204,394,000. Institutional investors own 30.19% of the company’s stock.

Olink Holding AB (publ) Price Performance

OLK opened at $26.08 on Monday. Olink Holding AB has a 1-year low of $14.10 and a 1-year high of $26.09. The business has a 50 day moving average price of $26.08 and a two-hundred day moving average price of $24.76. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of -96.59 and a beta of 0.52.

Olink Holding AB (publ) Profile

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.